• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

男性在机会性筛查后接受前列腺癌诊断的体验:定性描述性二次分析。

Men's experiences of receiving a prostate cancer diagnosis after opportunistic screening-A qualitative descriptive secondary analysis.

机构信息

Department of Neurobiology, Care Sciences and Society, Division of Nursing, Karolinska Institutet, Stockholm, Sweden.

Stockholm County Council, Academic Primary Health Care Center, Stockholm, Sweden.

出版信息

Health Expect. 2022 Oct;25(5):2485-2491. doi: 10.1111/hex.13567. Epub 2022 Jul 27.

DOI:10.1111/hex.13567
PMID:35898187
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9615043/
Abstract

BACKGROUND

Prostate cancer is one of the most common types of cancer in men and could occur without symptoms. Screening has been debated but remains controversial and, in most countries, organized population-based screening does not exist. The aim of this study was to describe men's experiences of receiving a prostate cancer diagnosis after opportunistic screening.

METHODS

This study is a secondary analysis from interviews with 17 men (aged 56-80 years) who had undergone curative treatment for prostate cancer. Data were collected in an urban region of Sweden through interviews conducted face to face or by telephone. An inductive content analysis was used with Consolidated criteria for Reporting Qualitative research as a reporting checklist.

RESULTS

Two main categories were identified. Screening is a lifesaver enclosed by ethical dilemmas reflects how men considered screening as a lifesaving test. Testing was surrounded by injustice and an eagerness to encourage other men to undergo screening. Facing challenges during diagnosis reflects the men's experiences of being in an unknown field yet expected to engage in decision-making concerning appropriate treatment. Receiving the diagnosis rendered mixed emotions about having a cancer disease, that the treatment could cause lifelong symptom distress and the men described being hesitant to talk about their diagnosis.

CONCLUSIONS

The findings highlight men's opinions about screening and that the lack of routine screening represents injustice. The men considered this as an ethical question of lifesaving justice, while stakeholders may argue that screening could lead to unnecessary suffering and overtreatment. Men do not always talk openly about their diagnosis, linked to the fact that it concerns intimate areas. It is important to balance the information in relation to shared decision-making regarding treatment. Health care professionals have an ethical responsibility to support and coach the patient in their decision.

PATIENT OR PUBLIC CONTRIBUTION

This study was based on interviews with men who had experienced a diagnosis of prostate cancer.

摘要

背景

前列腺癌是男性最常见的癌症类型之一,可能无症状发生。筛查一直存在争议,但仍存在争议,而且在大多数国家,没有组织的基于人群的筛查。本研究旨在描述男性在机会性筛查后接受前列腺癌诊断的经历。

方法

本研究是对 17 名(年龄 56-80 岁)接受过前列腺癌根治性治疗的男性进行访谈的二次分析。数据是通过在瑞典城市地区进行的面对面或电话访谈收集的。采用归纳内容分析法,以统一报告定性研究的标准作为报告检查表。

结果

确定了两个主要类别。筛查是一种拯救生命的手段,同时也存在伦理困境,反映了男性将筛查视为拯救生命的测试。检测被不公正和急于鼓励其他男性进行筛查所包围。在诊断过程中面临挑战反映了男性在未知领域的经历,但又期望参与有关适当治疗的决策。接受诊断会导致对患有癌症疾病的混合情绪,即治疗可能会导致终身症状困扰,并且男性描述自己对谈论诊断犹豫不决。

结论

研究结果强调了男性对筛查的看法,以及缺乏常规筛查代表不公正。男性认为这是一个关于拯救生命的正义的伦理问题,而利益相关者可能会认为筛查可能导致不必要的痛苦和过度治疗。男性并不总是公开谈论他们的诊断,这与它涉及到私密区域有关。在与治疗相关的共同决策中,平衡信息非常重要。医疗保健专业人员有责任支持和指导患者做出决策。

患者或公众贡献

本研究基于对经历过前列腺癌诊断的男性进行的访谈。

相似文献

1
Men's experiences of receiving a prostate cancer diagnosis after opportunistic screening-A qualitative descriptive secondary analysis.男性在机会性筛查后接受前列腺癌诊断的体验:定性描述性二次分析。
Health Expect. 2022 Oct;25(5):2485-2491. doi: 10.1111/hex.13567. Epub 2022 Jul 27.
2
A qualitative meta-synthesis examining the role of women in African American men's prostate cancer screening and treatment decision making.一项定性元分析研究,探讨了女性在非裔美国男性前列腺癌筛查和治疗决策中的作用。
Psychooncology. 2018 Mar;27(3):781-790. doi: 10.1002/pon.4572. Epub 2017 Nov 23.
3
Gay men's experiences of sexual changes after prostate cancer treatment-a qualitative study in Sweden.瑞典一项关于前列腺癌治疗后男同性恋者性变化经历的定性研究。
Scand J Urol. 2019 Feb;53(1):40-44. doi: 10.1080/21681805.2018.1563627. Epub 2019 Feb 7.
4
Delivering the unexpected-Information needs for PSA screening from Men's perspective: A qualitative study.从男性视角探讨前列腺特异性抗原(PSA)筛查信息需求:一项定性研究。
Health Expect. 2021 Aug;24(4):1403-1412. doi: 10.1111/hex.13275. Epub 2021 Jun 7.
5
Men's experiences of antenatal screening: a metasynthesis of the qualitative research.男性参与产前筛查的体验:定性研究的元分析
Int J Nurs Stud. 2013 Jan;50(1):121-33. doi: 10.1016/j.ijnurstu.2012.05.004. Epub 2012 Jun 7.
6
This is an older men's world: A qualitative study of men's experiences with prostate cancer.这是一个老年男性的世界:一项关于男性前列腺癌经历的定性研究。
Eur J Oncol Nurs. 2018 Dec;37:56-64. doi: 10.1016/j.ejon.2018.11.002. Epub 2018 Nov 3.
7
The influence of family ties on men's prostate cancer screening, biopsy, and treatment decisions.家庭关系对男性前列腺癌筛查、活检和治疗决策的影响。
Am J Mens Health. 2013 Nov;7(6):461-71. doi: 10.1177/1557988313480226. Epub 2013 Mar 3.
8
Men's preferences and trade-offs for prostate cancer screening: a discrete choice experiment.男性对前列腺癌筛查的偏好与权衡:一项离散选择实验
Health Expect. 2015 Dec;18(6):3123-35. doi: 10.1111/hex.12301. Epub 2014 Nov 10.
9
Exploring men's struggles with infertility: A qualitative content analysis.探索男性在不孕不育方面的挣扎:一项定性内容分析。
J Adv Nurs. 2024 May;80(5):2018-2026. doi: 10.1111/jan.15958. Epub 2023 Nov 14.
10
Men's perception of information and descriptions of emotional strain in the diagnostic phase of prostate cancer-a qualitative individual interview study.男性在前列腺癌诊断阶段对信息的感知和对情绪压力的描述——一项定性个体访谈研究。
Scand J Prim Health Care. 2021 Dec;39(4):476-485. doi: 10.1080/02813432.2021.2004734. Epub 2021 Nov 21.

引用本文的文献

1
Barriers and sources of information in prostate cancer screening at a South African hospital.南非一家医院前列腺癌筛查中的信息障碍与信息来源
J Public Health Afr. 2025 Apr 12;16(1):666. doi: 10.4102/jphia.v16i1.666. eCollection 2025.
2
Men's experiences of the Swedish Organised Prostate Cancer Testing programme: a qualitative study.男性参与瑞典有组织前列腺癌检测项目的经历:一项定性研究。
BJU Int. 2025 Aug;136(2):254-260. doi: 10.1111/bju.16735. Epub 2025 Apr 6.
3
Preferences for Tailored Support - Patients' and Health Care Professionals' Experiences Regarding Symptoms and Self-Management Strategies During the First Year After Curatively Intended Prostate Cancer Treatment.对个性化支持的偏好——根治性前列腺癌治疗后第一年患者及医疗保健专业人员关于症状和自我管理策略的体验
Patient Prefer Adherence. 2024 Feb 2;18:275-288. doi: 10.2147/PPA.S440689. eCollection 2024.

本文引用的文献

1
Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial.使用风险预测、MRI 和靶向前列腺活检的组合进行前列腺癌筛查(STHLM3-MRI):一项前瞻性、基于人群、随机、开放标签、非劣效性试验。
Lancet Oncol. 2021 Sep;22(9):1240-1249. doi: 10.1016/S1470-2045(21)00348-X. Epub 2021 Aug 13.
2
Shared decision making, physicians' explanations, and treatment satisfaction: a cross-sectional survey of prostate cancer patients.共同决策、医生的解释与治疗满意度:一项针对前列腺癌患者的横断面调查。
BMC Med Inform Decis Mak. 2020 Dec 14;20(1):334. doi: 10.1186/s12911-020-01355-z.
3
PSA testing patterns in a large Swedish cohort before the implementation of organized PSA testing.在实施有组织的 PSA 检测之前,在一个大型瑞典队列中进行 PSA 检测的模式。
Scand J Urol. 2020 Oct;54(5):376-381. doi: 10.1080/21681805.2020.1797871. Epub 2020 Jul 31.
4
The shared decision-making model: Providers' and patients' knowledge and understanding in clinical practice.共享决策模型:临床实践中医疗服务提供者与患者的知识及理解
J Am Assoc Nurse Pract. 2020 Jun 30;33(7):529-536. doi: 10.1097/JXX.0000000000000401.
5
Opportunistic prostate cancer screening: A population-based analysis.机会性前列腺癌筛查:基于人群的分析。
Urol Oncol. 2020 May;38(5):393-400. doi: 10.1016/j.urolonc.2019.12.009. Epub 2020 Jan 14.
6
Person-centred shared decision making.以人为本的共享决策。
J Eval Clin Pract. 2019 Dec;25(6):1057-1062. doi: 10.1111/jep.13260. Epub 2019 Aug 12.
7
Prostate Cancer Screening: Shared Decision-Making for Screening and Treatment.前列腺癌筛查:筛查与治疗的共同决策
Prim Care. 2019 Mar;46(1):149-155. doi: 10.1016/j.pop.2018.10.012. Epub 2018 Dec 24.
8
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
9
Understanding Medical Decision-making in Prostate Cancer Care.了解前列腺癌治疗中的医疗决策
Am J Mens Health. 2018 Sep;12(5):1635-1647. doi: 10.1177/1557988318780851. Epub 2018 Jun 7.
10
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study.全球、区域和国家癌症发病率、死亡率、生命损失年数、失能生存年数以及 29 种癌症组别的伤残调整生命年数,1990 年至 2016 年:全球疾病负担研究的系统分析。
JAMA Oncol. 2018 Nov 1;4(11):1553-1568. doi: 10.1001/jamaoncol.2018.2706.